findmyKOL
Clinical trialNCT06954597RecruitingPhase 2Interventional

Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis

SponsorTopadur Pharma AGEnrollment15Digital Ulcers in Systemic Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Centre Hospitalier Universitaire de Bordeaux, Service de Rhumatologie

    Bordeaux, France

    Marie-Elise Truchetet, Professeur
    Recruiting
  • Chu Grenoble Alpes

    La Tronche, France

    Sophie Blaise, Professor
    Recruiting
  • Chru Lille, Hôpital Claude Huriez, Rue Michel Polonosvski

    Lille, France

    David Launay, Prof
    Recruiting
  • Ap-Hp Hôpital Cochin

    Paris, France

    Yannick Allanore, Professor
    Recruiting
Switzerland
  • Reha Rheinfelden, Salinenstrasse 98

    Rheinfelden, Canton of Aargau, Switzerland

    Ulrich Gerth, Dr
    Recruiting
  • Universitätsspital Zürich, Klinik Für Rheumatologie, Rämistrasse 100

    Zurich, Canton of Zurich, Switzerland

    Chantal Meier, Dr
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Feb 2025
Primary completion
31 Oct 2026
Completion
31 Oct 2026
Last update posted
15 Jun 2026
Registered enrollment
15
Registry id
NCT06954597

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-511861-12-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.